The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CREB5 as an essential transcription and tumorigenic regulator in basal-like breast and prostate cancer.
 
Allison Makovec
No Relationships to Disclose
 
Sydney Tape
No Relationships to Disclose
 
Hannah E. Bergom
No Relationships to Disclose
 
Camden Richter
No Relationships to Disclose
 
Aiden Deacon
No Relationships to Disclose
 
Atef Mir Ali
No Relationships to Disclose
 
Jonathan Rennhack
No Relationships to Disclose
 
Megan Ludwig
No Relationships to Disclose
 
Emmanuel S. Antonarakis
Consulting or Advisory Role - AADi; AIkido Pharma; Amgen; AstraZeneca; Bayer (Inst); Blue Earth Diagnostics; Corcept Therapeutics; Curium Pharma; Foundation Medicine; Hookipa Pharma; Janssen Biotech; Lilly; Menarini Silicon Biosystems; Merck; Pfizer; Sanofi; Tango Therapeutics; Tempus; Z-Alpha
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Macrogenics (Inst); Merck (Inst); Orion Health (Inst)
Patents, Royalties, Other Intellectual Property - Co-inventor of a biomarker technology that has been licensed to Qiagen
 
Justin Drake
Employment - Astrin Biosciences
Leadership - Astrin Biosciences
Stock and Other Ownership Interests - Astrin Biosciences
Consulting or Advisory Role - Astrin Biosciences
Research Funding - Astrin Biosciences
Patents, Royalties, Other Intellectual Property - Royalty from work done supported by a research sponsored grant from Astrin Biosciences
 
Justin Hwang
Research Funding - Astrin Biosciences